Home/Filings/4/0000899243-23-006241

4//SEC Filing

AFEYAN NOUBAR 4

Accession 0000899243-23-006241

CIK 0001850838other

View on SEC.gov Company Profile

Filed

Feb 26, 7:00 PM ET

Accepted

Feb 27, 5:20 PM ET

Size

20.5 KB

Accession

0000899243-23-006241

Insider Transaction Report

Form 4

Period: 2023-02-27

Omega Therapeutics, Inc.OMGA

AFEYAN NOUBAR

Director10% Owner

Transactions

Purchase
Common Stock
2023-02-27$5.78/sh+1,329,324$7,683,493→ 1,329,324 total(indirect: By Flagship Pioneering Fund VII, L.P.)
Purchase
Common Stock
2023-02-27$5.78/sh+1,993,986$11,525,239→ 7,508,693 total(indirect: By Flagship Pioneering Special Opportunities Fund II, L.P.)

Holdings

Common Stock
(indirect: By Flagship V VentureLabs Rx Fund, L.P.)
1,088,470
Common Stock
(indirect: By Flagship Ventures Fund V, L.P.)
5,896,386
Common Stock
(indirect: By Flagship Pioneering Fund VI, L.P.)
8,617,413
Common Stock
(indirect: By Nutritional Health LTP Fund, L.P.)
970,588
Common Stock
(indirect: By FPN, L.P.)
1,617,646
Common Stock
(indirect: By LLC)
2,197,059

Flagship Pioneering, LLC

10% Owner

Transactions

Purchase
Common Stock
2023-02-27$5.78/sh+1,993,986$11,525,239→ 7,508,693 total(indirect: By Flagship Pioneering Special Opportunities Fund II, L.P.)
Purchase
Common Stock
2023-02-27$5.78/sh+1,329,324$7,683,493→ 1,329,324 total(indirect: By Flagship Pioneering Fund VII, L.P.)

Holdings

Common Stock
(indirect: By Flagship V VentureLabs Rx Fund, L.P.)
1,088,470
Common Stock
(indirect: By Flagship Ventures Fund V, L.P.)
5,896,386
Common Stock
(indirect: By Flagship Pioneering Fund VI, L.P.)
8,617,413
Common Stock
(indirect: By Nutritional Health LTP Fund, L.P.)
970,588
Common Stock
(indirect: By FPN, L.P.)
1,617,646
Common Stock
(indirect: By LLC)
2,197,059

Flagship Pioneering Special Opportunities Fund II General Partner LLC

10% Owner

Transactions

Purchase
Common Stock
2023-02-27$5.78/sh+1,993,986$11,525,239→ 7,508,693 total(indirect: By Flagship Pioneering Special Opportunities Fund II, L.P.)
Purchase
Common Stock
2023-02-27$5.78/sh+1,329,324$7,683,493→ 1,329,324 total(indirect: By Flagship Pioneering Fund VII, L.P.)

Holdings

Common Stock
(indirect: By Flagship V VentureLabs Rx Fund, L.P.)
1,088,470
Common Stock
(indirect: By Flagship Ventures Fund V, L.P.)
5,896,386
Common Stock
(indirect: By Flagship Pioneering Fund VI, L.P.)
8,617,413
Common Stock
(indirect: By Nutritional Health LTP Fund, L.P.)
970,588
Common Stock
(indirect: By FPN, L.P.)
1,617,646
Common Stock
(indirect: By LLC)
2,197,059

Flagship Pioneering Special Opportunities Fund II, L.P.

10% Owner

Transactions

Purchase
Common Stock
2023-02-27$5.78/sh+1,993,986$11,525,239→ 7,508,693 total(indirect: By Flagship Pioneering Special Opportunities Fund II, L.P.)
Purchase
Common Stock
2023-02-27$5.78/sh+1,329,324$7,683,493→ 1,329,324 total(indirect: By Flagship Pioneering Fund VII, L.P.)

Holdings

Common Stock
(indirect: By Flagship Ventures Fund V, L.P.)
5,896,386
Common Stock
(indirect: By Flagship Pioneering Fund VI, L.P.)
8,617,413
Common Stock
(indirect: By Nutritional Health LTP Fund, L.P.)
970,588
Common Stock
(indirect: By FPN, L.P.)
1,617,646
Common Stock
(indirect: By LLC)
2,197,059
Common Stock
(indirect: By Flagship V VentureLabs Rx Fund, L.P.)
1,088,470

Footnotes (9)

[F1]On February 27, 2023, Flagship Pioneering Special Opportunities Fund II, L.P. ("Flagship Opportunities Fund II") and Flagship Pioneering Fund VII, L.P. ("Flagship Fund VII") purchased 1,993,986 shares and 1,329,324 shares, respectively, of the Issuer's Common Stock in a registered direct offering at a price of $5.78 per share pursuant to a Securities Purchase Agreement dated February 22, 2023.
[F2]Represents shares held directly by Flagship Opportunities Fund II. Flagship Pioneering Special Opportunities Fund II General Partner LLC ("Flagship Opportunities Fund II GP") is the general partner of Flagship Opportunities Fund II. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of Flagship Opportunities Fund II GP. Noubar B. Afeyan, Ph.D. is the Chief Executive Officer, sole shareholder and director of Flagship Pioneering. Each of the reporting persons except Flagship Opportunities Fund II disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
[F3]Represents shares held directly by Flagship Fund VII. Flagship Pioneering Fund VII General Partner LLC ("Flagship Fund VII GP") is the general partner of Flagship Fund VII. Flagship Pioneering is the manager of Flagship Fund VII GP. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
[F4]Represents shares held directly by Flagship V VentureLabs Rx Fund, L.P. ("Flagship Fund V Rx"). Flagship Ventures Fund V General Partner LLC ("Flagship V GP") is the general partner of Flagship Fund V Rx. Dr. Afeyan is the sole manager of Flagship V GP. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
[F5]Represents shares held directly by Flagship Ventures Fund V, L.P. ("Flagship Fund V"). Flagship V GP is the general partner of Flagship Fund V. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
[F6]Represents shares held directly by Flagship Pioneering Fund VI, L.P. ("Flagship Fund VI"). Flagship Pioneering Fund VI General Partner LLC ("Flagship Fund VI GP") is the general partner of Flagship Fund VI. Flagship Pioneering is the manager of Flagship Fund VI GP. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
[F7]Represents shares held directly by Nutritional Health LTP Fund, L.P. ("Nutritional LTP"). Nutritional Health LTP Fund General Partner LLC ("Nutritional LTP GP") is the general partner of Nutritional LTP. Flagship Pioneering is the manager of Nutritional LTP GP. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
[F8]Represents shares held directly by FPN, L.P. ("FPN Fund"). FPN General Partner LLC ("FPN GP") is the general partner of FPN Fund. Flagship Pioneering is the manager of FPN GP. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.
[F9]Represents shares held directly by Flagship VentureLabs V, LLC ("VentureLabs V"). VentureLabs V Manager LLC ("VentureLabs V Manager") is the manager of VentureLabs V. Flagship Pioneering, Inc. ("Flagship Pioneering") is the manager of VentureLabs V Manager. Each of the reporting persons disclaims beneficial ownership of such shares except to the extent of his or its pecuniary interest therein, if any.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Omega Therapeutics, Inc.

CIK 0001850838

→

Entity typeother

Related Parties

filerCIK 0001222012

Filing Metadata

Form type: 4
Filed: Feb 26, 7:00 PM ET
Accepted: Feb 27, 5:20 PM ET
Size: 20.5 KB

View on SEC.gov